APEX Ventures is a European venture capital firm focusing on deep tech companies, with its medical fund targeting early-stage healthcare startups enabled by novel technologies.
Portfolio
5
companies
Upfront Diagnostics
Upfront Diagnostics develops rapid point-of-care blood tests for the rapid detection of strokes.
Zetta Genomics
Zetta Genomics builds genomic data analysis platforms for precision medicine and healthcare.
CardiaTec Biosciences
CardiaTec Biosciences applies artificial intelligence to multiomic data for cardiovascular drug discovery.
VividQ
VividQ creates software and intellectual property for computer-generated holography in digital displays.
Novoic
Novoic develops speech-based artificial intelligence algorithms for early neurological disease detection.
Hermann Hauser
Advisor
Pooja Sikka
Venture Partner
Gordon Euller
Partner
The seed round was led by APEX Ventures Medical Fund with backing from SBRI Healthcare and the Stroke Association.
"With this significant funding, we are poised to transform stroke diagnosis worldwide and make a tangible impact on patient care."
Nina Capital led the seed follow on round to support international growth and product scaling.
"Today’s seed funding exceeded our initial ask, showing the excitement building around Zetta Genomics’ game changing XetaBase data analytics platform. We now have the strategic headroom to configure for growth – to scale our technologies, enhance customer focus, and create a cycle of ongoing product innovation. This investment sees us one step closer to realising predictive, precision genomics – transforming research, healthcare and the lives of millions."
The pre-seed round was co-led by Laidlaw Scholars Ventures and APEX Ventures.
"Recent advances in artificial intelligence are generating novel ways to interpret multiomic data. I am excited to lead CardiaTec’s technology strategy to establish a new paradigm for understanding the pathophysiology of cardiovascular diseases."
The funding round was led by UTokyo Innovation Platform and will be used to expand operations and accelerate product development.
"Scenes we know from films, from Iron Man to Star Trek, are becoming closer to reality than ever. At VividQ, we are on a mission to bring holographic displays to the world for the first time. Our solutions help bring innovative display products to the automotive industry, improve AR experiences, and soon will change how we interact with personal devices, such as laptops and mobiles."
Anthemis Exponential Ventures led the seed round with participation from APEX Ventures and Entrepreneur First.
"The current pandemic vividly shows the need for digital, non-invasive technologies for clinical diagnosis and monitoring. Clinical trials are on hold, with regulators advising on the use of novel remote endpoints to salvage the trials. At the same time, the shift towards telemedicine models is further accelerating the adoption of digital technologies in the health care sectors. Novoic–with its next generation algorithms and strong focus on clinical validation–is best positioned to drive this acceleration."
